Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug;34(3):403-415.
doi: 10.1016/j.hcl.2018.03.009.

Treatment of Recurrent Dupuytren Disease

Affiliations
Review

Treatment of Recurrent Dupuytren Disease

Frederick Thomas D Kaplan et al. Hand Clin. 2018 Aug.

Abstract

Treatment of recurrent Dupuytren disease is challenging. Multiple options exist, each having relative benefits and weaknesses. Choice for optimal treatment is made on a case-by-case basis, with shared decision making with the patient. Percutaneous and enzymatic techniques are best reserved for patients with well-defined recurrent disease and offer the benefit of quicker recovery with minimal or no scarring. Surgical treatments have higher risks of neurovascular injury and scarring, but lower recurrence rates. Staged continuous passive elongation followed by dermofasciectomy may lower neurovascular injury and improve outcomes. Salvage procedures may be necessary in patients with poor tissue beds and neurovascular compromise.

Keywords: Aponeurotomy; Collagenase Clostridium histolyticum; Continuous passive elongation; Dermofasciectomy; Dupuytren disease; Outcomes; Recurrence.

PubMed Disclaimer

Substances

LinkOut - more resources